Don't swallow dog's breakfast deal at Arix Bioscience
Four years on and Neil Woodford’s portfolio is still coming back to bite. The latest case in point? Arix Bioscience, once a darling of the fallen stockpicker b
Stay updated with breaking news from Arix Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Four years on and Neil Woodford’s portfolio is still coming back to bite. The latest case in point? Arix Bioscience, once a darling of the fallen stockpicker b
The London Stock Exchange is set to lose as many as 30 £100m-plus firms from public markets this year, a figure bringing into sharp relief the troubles on London's public equity markets.
The portfolio of Arix Bioscience, the listed life sciences investment company once backed by Neil Woodford, is to be bought by an American investment firm,
Too many companies are delisting from the London Stock Exchange. It's time for a little less conversation and a little more action, says City A.M.
Investegate announcements from PDMR Notification & Director Shareholding